ArticleMethods in molecular biology (Clifton, N.J.)2026
Transition State-Based Computational Enzyme Design.
Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Our approach to computational protein design is physics-based. We develop a software called Proteus, allowing both physics-based energy evaluation and sequence-conformation exploration. Unlike knowledge-based models, a physics-based energy function facilitates the consideration of unusual chemical entities, such as novel ligands or transition states. Additionally, the adaptive landscape flattening method allows direct sampling on free energy difference between two states. We show here how these ingredients combined can benefit enzyme design. As an illustration, we revisit the stereospecificity inversion of tyrosyl-tRNA synthetase. Following a tutorial presentation, we explore various design criteria that can be related to enzyme experimental parameters. Our model is able to retrieve the native sequence when targeting L-tyrosine. Mutations predicted to favor D-tyrosine are proposed.
Indexed as
Identifiers
41174313What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.